RPRX
Royalty Pharma plc · Healthcare
EVP & Chairman, Partnering Christopher Hite sold $8.2M of Royalty Pharma plc
Sold$8,159,277
$54.40Price
150,000Shares
−21%Stake
What RPRX did after the filing
- The stock from Fri, Jun 26 open, $54.60
- +6.2%
- S&P 500, same days
- +6.0%
Measured over 30 trading days, to the Aug 10 close.
Traded Tue, Jun 23. Filed Thu, Jun 25, 5:11 PM ET, after the close. Returns use the Jun 26 open and the Aug 10 close. Not investment advice.